IGFLR1
IGF-like family receptor 1
Also known as: FLJ22573, IGFR1_HUMAN, TMEM149, U2AF1L4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H665
- Gene
- IGFLR1
- Ensembl
- ENSG00000126246
- Chromosome
- 19
- Canonical length
- 355 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
355 residues, UniProt reviewed canonical sequence.
>Q9H665|IGFLR1
1 MGPGRCLLTA LLLLALAPPP EASQYCGRLE YWNPDNKCCS SCLQRFGPPP CPDYEFRENC
61 GLNDHGDFVT PPFRKCSSGQ CNPDGAELCS PCGGGAVTPT PAAGGGRTPW RCRERPVPAK
121 GHCPLTPGNP GAPSSQERSS PASSIAWRTP EPVPQQAWPN FLPLVVLVLL LTLAVIAILL
181 FILLWHLCWP KEKADPYPYP GLVCGVPNTH TPSSSHLSSP GALETGDTWK EASLLPLLSR
241 ELSSLASQPL SRLLDELEVL EELIVLLDPE PGPGGGMAHG TTRHLAARYG LPAAWSTFAY
301 SLRPSRSPLR ALIEMVVARE PSASLGQLGT HLAQLGRADA LRVLSKLGSS GVCWALocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGFLR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- liver: 47 nTPM
- lymph node: 31 nTPM
- spleen: 27 nTPM
- tonsil: 22 nTPM
- appendix: 18 nTPM
- kidney: 14 nTPM
Single-cell type
- pdcs: 23 nCPM
- hepatocytes: 22 nCPM
- cdc: 17 nCPM
- hofbauer cells: 13 nCPM
- tuft cells: 12 nCPM
- monocytes: 10 nCPM
Immune cell
- plasmacytoid DC: 902 nTPM
- myeloid DC: 254 nTPM
- neutrophil: 209 nTPM
- classical monocyte: 191 nTPM
- eosinophil: 185 nTPM
- naive B-cell: 173 nTPM
Brain region
- hypothalamus: 16 nTPM
- medulla oblongata: 15 nTPM
- cerebral cortex: 13 nTPM
- thalamus: 12 nTPM
- pons: 12 nTPM
- white matter: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.8
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Death-like domain superfamily
- IGF-like family receptor 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGFLR1 as an antibody target. Whether an autoantibody or antibody against IGFLR1 could matter depends on whether native IGFLR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGFLR1 is annotated at the cell surface, where native IGFLR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGFLR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...